Industry: Drug Manufacturers - Specialty & Generic
CEO:Mr. Xiang Miao
Full-time employees:2018
City:Shenzhen
Address:Science and Technology Park
IPO:2017-02-08
CIK:
Website:
General Outlook
In simple terms, Shenzhen Kangtai Biological Products Co., Ltd. has 1108.962 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.832% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.213%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.224%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.047% return, is a testament to Shenzhen Kangtai Biological Products Co., Ltd.'s adeptness in optimizing resource deployment. Shenzhen Kangtai Biological Products Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.074%. Furthermore, the proficiency of Shenzhen Kangtai Biological Products Co., Ltd. in capital utilization is underscored by a remarkable 0.055% return on capital employed.
Stock Prices
Shenzhen Kangtai Biological Products Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $22.63, while its low point bottomed out at $21.94. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shenzhen Kangtai Biological Products Co., Ltd.'s stock market.
Liquidity Ratios
Analyzing 300601.SZ liquidity ratios reveals its financial health of the firm.
The current ratio of 181.92% gauges short-term asset coverage for liabilities.
The quick ratio (135.58%) assesses immediate liquidity, while the cash ratio (31.91%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
181.92%
Quick Ratio
135.58%
Cash Ratio
31.91%
Profitability Ratios
300601.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 24.11% underscores its earnings before tax deductions.
The effective tax rate stands at 7.04%, revealing its tax efficiency.
The net income per EBT, 92.96%, and the EBT per EBIT, 113.13%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 21.31%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
24.11%
Effective Tax Rate
7.04%
Net Income per EBT
92.96%
EBT per EBIT
113.13%
EBIT per Revenue
21.31%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 1.82, it details the span from stock purchase to revenue.
The 1 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
136
Days of Inventory Outstanding
616
Operating Cycle
929.79
Days of Payables Outstanding
470
Cash Conversion Cycle
460
Receivables Turnover
1.16
Payables Turnover
0.78
Inventory Turnover
0.59
Fixed Asset Turnover
0.55
Asset Turnover
0.21
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.79, and free cash flow per share, 0.16, depict cash generation on a per-share basis.
The cash per share value, 0.89, showcases liquidity position.
A payout ratio of 0.33 highlights the portion of earnings distributed as dividends.
Lastly, the operating cash flow sales ratio, 0.28, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
0.79
Free Cash Flow per Share
0.16
Cash per Share
0.89
Payout Ratio
0.33
Operating Cash Flow Sales Ratio
0.28
Free Cash Flow to Operating Cash Flow Ratio
0.21
Cash Flow Coverage Ratio
0.32
Short Term Coverage Ratio
1.99
Capital Expenditure Coverage Ratio
1.26
Dividend Paid and Capex Coverage Ratio
0.94
Dividend Payout Ratio
0.01
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 18.16%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.28, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 19.18%, and total debt to capitalization, 22.09%, ratios shed light on its capital structure.
An interest coverage of 5.67 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
18.16%
Debt Equity Ratio
0.28
Long Term Debt to Capitalization
19.18%
Total Debt to Capitalization
22.09%
Interest Coverage
5.67
Cash Flow to Debt Ratio
0.32
Company Equity Multiplier
1.56
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 3.09, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 0.77, reflects the portion of profit attributed to each share.
The book value per share, 8.53, represents the net asset value distributed per share, while the tangible book value per share, 8.37, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
3.09
Net Income Per Share
0.77
Book Value Per Share
8.53
Tangible Book Value Per Share
8.37
Shareholders Equity Per Share
8.53
Interest Debt Per Share
2.38
Capex Per Share
-0.64
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 9.32%, indicates top-line expansion, while the gross profit growth, 6.46%, reveals profitability trends.
EBIT growth, 3.72%, and operating income growth, 3.72%, offer insights into operational profitability progression.
The net income growth, 749.02%, showcases bottom-line expansion, and the EPS growth, 741.67%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
9.32%
Gross Profit Growth
6.46%
EBIT Growth
3.72%
Operating Income Growth
3.72%
Net Income Growth
749.02%
EPS Growth
741.67%
EPS Diluted Growth
741.67%
Weighted Average Shares Growth
1.15%
Weighted Average Shares Diluted Growth
1.15%
Dividends per Share Growth
-62.30%
Operating Cash Flow Growth
100.43%
Free Cash Flow Growth
149.07%
10-Year Revenue Growth per Share
994.57%
5-Year Revenue Growth per Share
52.37%
3-Year Revenue Growth per Share
43.99%
10-Year Operating CF Growth per Share
3192.94%
5-Year Operating CF Growth per Share
189.39%
3-Year Operating CF Growth per Share
134.54%
10-Year Net Income Growth per Share
45194.12%
5-Year Net Income Growth per Share
76.00%
3-Year Net Income Growth per Share
19.61%
10-Year Shareholders Equity Growth per Share
1936.64%
5-Year Shareholders Equity Growth per Share
363.49%
3-Year Shareholders Equity Growth per Share
20.58%
10-Year Dividend per Share Growth per Share
493.29%
5-Year Dividend per Share Growth per Share
229.52%
3-Year Dividend per Share Growth per Share
7.93%
Receivables Growth
16.75%
Inventory Growth
6.19%
Asset Growth
9.42%
Book Value per Share Growth
4.99%
Debt Growth
11.23%
R&D Expense Growth
-42.96%
SGA Expenses Growth
29.14%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 31,138,663,759.11, captures the company's total value, considering both debt and equity.
Income quality, 1.27, assesses the reliability of reported earnings.
The sales, general, and administrative to revenue ratio, 0.02, gauges operational efficiency, while the research and development to revenue, 13.25%, highlights investment in innovation.
The ratio of intangibles to total assets, 3.34%, indicates the value of non-physical assets, and capex to operating cash flow, -65.69%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
31,138,663,759.11
Income Quality
1.27
Sales General and Administrative to Revenue
0.02
Research and Development to Revenue
13.25%
Intangibles to Total Assets
3.34%
Capex to Operating Cash Flow
-65.69%
Capex to Revenue
-20.81%
Capex to Depreciation
-298.46%
Stock-Based Compensation to Revenue
0.09%
Graham Number
12.16
Return on Tangible Assets
5.91%
Graham Net Net
-0.85
Working Capital
2,644,653,029
Tangible Asset Value
9,366,148,649
Net Current Asset Value
181,032,454
Average Receivables
2,616,974,392.5
Average Payables
612,654,764.5
Average Inventory
750,326,511
Days Sales Outstanding
298
Days Payables Outstanding
464
Days of Inventory On Hand
453
ROIC
5.87%
ROE
0.09%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.48, and the price to book ratio, 2.48, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 7.47, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 128.73, and price to operating cash flows, 26.95, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
2.48
Price to Book Ratio
2.48
Price to Sales Ratio
7.47
Price Cash Flow Ratio
26.95
Price Earnings to Growth Ratio
0.26
Enterprise Value Multiple
23.01
Price Fair Value
2.48
Price to Operating Cash Flow Ratio
26.95
Price to Free Cash Flows Ratio
128.73
Price to Tangible Book Ratio
3.12
Enterprise Value to Sales
9.02
Enterprise Value Over EBITDA
30.66
EV to Operating Cash Flow
28.47
Earnings Yield
2.89%
Free Cash Flow Yield
1.26%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
